- MAB 01-22-13 (PDF)
Updates to blood lead reference value and environmental lead investigation provider qualifications requirements
- MAB 99-22-03 (PDF)
2022 recommended child and adolescent immunization schedule
- MAB 08-21-07 (PDF)
Naloxone distribution by federally qualified health centers and rural health clinics
- MAB 09-21-04 (PDF)
Coverage of home accessibility durable medical equipment and procedure for obtaining an 1150 administrative waiver in the fee-for-service delivery system
- MAB 01-21-04 (PDF)
SARS-CoV-2 Vaccine Administration for Beneficiaries Who Are Homebound
- MAB 01-21-11 (PDF)
Expansion of Providers for the Administration of SARS-CoV-2 Vaccines and Monoclonal Antibody Therapy
- MAB 99-21-03 (PDF)
Reinstatement of Prior Authorization Requirements for Certain Services
- MAB Provider Preventable Conditions (PDF)
- MAB 01-21-03 (PDF)
Fee increase for the administration of SARS-CoV-2 vaccines
- MAB 01-21-01 (PDF)
Janssen Biotech Inc. SARS-CoV-2 vaccine added to MA fee schedule
- MAB 01-20-62
SARS-CoV-2 Vaccine Updates
- MAB 01-20-08
Addition of Opioid Use Disorder Centers of Excellence Provider Specialty
- MAB 01-20-06
Updates to Childhood Nutrition and Weight Management Services
- MAB 01-19-65
Statewide Preferred Drug List (PDL) Implementation
- MAB 01-19-46
Certified Recovery Specialists in Centers of Excellence Bulletin
- MAB 99-18-11
Service Location Enrollment Deadline
- MAB March 1, 2019
Changes to Third-Party Liability Requirements for Claims for Prenatal Services
- MAB 99-17-11
Limited English Proficiency Requirements
- MAB 99-17-02
Submission of Claims that Require the National Provider Identifier (NPI) of a Medical Assistance enrolled Ordering, Referring or Prescribing Provider
- MAB 99-11-05
Provider Screening of Employees and Contractors for Exclusion from Participation in Federal Health Care Programs and the Effect of Exclusion on Participation
- MAB 99-99-06
Payment in full
- MAB 99-10-14
Missed appointments
